Irinotecan (CPT-11): pharmacology and clinical applications
- 30 September 1996
- journal article
- review article
- Published by Elsevier in Critical Reviews in Oncology/Hematology
- Vol. 24 (1), 3-26
- https://doi.org/10.1016/1040-8428(96)00201-6
Abstract
No abstract availableThis publication has 39 references indexed in Scilit:
- Phase II study of CPT-11, a new camptothecin derivative, in metastatic colorectal cancer. CPT-11 Gastrointestinal Cancer Study Group.Journal of Clinical Oncology, 1993
- CPT-11: a new derivative of camptothecin for the treatment of refractory or relapsed small-cell lung cancer.Journal of Clinical Oncology, 1992
- A phase II study of CPT-11, a new derivative of camptothecin, for previously untreated non-small-cell lung cancer.Journal of Clinical Oncology, 1992
- Synthesis and Antitumor Activity of 20(S)-Camptothecin Derivatives: Carbamate-Linked, Water-Soluble Derivatives of 7-Ethyl-10-hydroxycamptothecin.CHEMICAL & PHARMACEUTICAL BULLETIN, 1991
- CPT-11 Converting Enzyme from Rat Serum: Purification and Some Properties.Journal of Pharmacobio-Dynamics, 1991
- New Natural Products in Cancer ChemotherapyThe Journal of Clinical Pharmacology, 1990
- Antitumor effect of CPT-11, a new derivative of camptothecin, against pleiotropic drug-resistant tumors in vitro and in vivoCancer Chemotherapy and Pharmacology, 1988
- Antitumor activity of a new camptothecin derivative, SN-22, against various murine tumors.Journal of Pharmacobio-Dynamics, 1987
- Plant antitumor agents. 18. Synthesis and biological activity of camptothecin analogsJournal of Medicinal Chemistry, 1980
- Plant Antitumor Agents. I. The Isolation and Structure of Camptothecin, a Novel Alkaloidal Leukemia and Tumor Inhibitor from Camptotheca acuminata1,2Journal of the American Chemical Society, 1966